Last checked at 
(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)
U.S. stocks fell at the open on Monday as traders focused onevents in Washington after weekend talks between Republicans andDemocrats left the risk of a possible U.S. default alive.
The Dow Jones industrial average was down 0.61percent. The Standard & Poor's 500 Index was down 0.62percent while the Nasdaq Composite Index was down 0.61percent.
** FACEBOOK INC, $48.28, down 1.7 pct (9:31 a.m. ET)
The social networking company said it would buy start-upapp-maker Onavo, the Israeli firm said on its website, withoutgiving any details of the deal. Facebook is paying between $150million and $200 million, the Calcalist financial news websitereported, making it the social media company's biggestacquisition in Israel.
** NETFLIX INC, $309.35, up 2.8 pct (9:31 a.m. ET)
The company is in talks with several U.S. cable televisioncompanies including Comcast Corp and SuddenlinkCommunications to make its streaming video service availablethrough their set-top boxes, the Wall Street Journal reported onSunday, citing people familiar with the matter.
** CORONADO BIOSCIENCES INC, $1.81, down 69 pct(9:41 a.m. ET)
The company said its treatment for Crohn's disease, a typeof inflammatory bowel disease, failed the main goal of improvingpatients' response to the disease in a mid-stage study.
** MERCK & CO INC, $46.92, down 0.8 pct (9:31 a.m.ET)
The German drugs and healthcare group is in talkswith external investors including private equity firms to sharethe cost of some clinical trials, the Financial Times reported,citing a senior manager at the company.
** ADVANCED MICRO DEVICES, $3.87, up 1 pct (9:31a.m. ET)
Brokerage Wedbush Securities upgraded the chipmaker's stockto "outperform" from "neutral," saying AMD will benefit from thelaunch of gaming consoles in the near term. The brokerage alsoexpects the company to gain market share in servers. Wedbushraised its price target on the stock to $5.00 from $4.50.
** NEWMONT MINING CORP, $25.90, up 1 pct (9:32 a.m.ET)
HSBC Securities raised its price target on the gold miner'sstock to $37.30 from $36.50, maintaining its "overweight"rating.
Spot gold prices rose 0.7 percent to $1,281.96 anounce by 1135 GMT on Monday as the U.S. fiscal impasse remainedunresolved.
** ARCELORMITTAL SA, $15.22, up 2 pct (9:32 a.m. ET)
Analysts at Macquarie Equities Research raised their ratingon the world's largest steelmaker's stock to "outperform" from"neutral," according to Theflyonthewall.com.
** EXPEDIA INC, $49.25, down 5 pct (9:33 a.m. ET)
Deutsche Bank cut its rating on the online travel agency'sstock to "hold" from "buy," according to Theflyonthewall.com.
** PEABODY ENERGY CORP, $17.31, down 0.5 pct (9:33a.m. ET)
The company said it had temporarily shut down operations atits Metropolitan coal mine in Queensland, Australia, pre-emptinga planned strike by workers after a stand-off over a newemployment contract.
** GENERAL MOTORS CO, $34.99, down 1 pct (9:34 a.m.ET)
** TESLA MOTORS INC, $176.12, down 1 pct
General Motors will go head to head with electric car makerTesla Motors starting in January, when a plug-in version of itsluxury Cadillac brand will go on sale. GM said its 2014 CadillacELR plug-in coupe will have a starting price of almost $76,000including delivery fees - putting it in competition with thesimilarly priced Tesla Model S.
** SUPERIOR ENERGY SERVICES INC, $25.59, down 1 pct(9:35 a.m. ET)
The oilfield services company said it expected third-quarterearnings to fall to between 39 cents and 41 cents per share from59 cents a year earlier due to a slowdown in land drilling inthe United States. Superior Energy also said its boardauthorized a share buyback program of up to $400 million.
** MANNKIND CORP, $5.23, up 2 pct (9:35 a.m. ET)
The drugmaker resubmitted the application for approval toits insulin therapy, Afrezza, to the U.S. health regulator basedon clinical development data, including the results of tworecent late-stage trials in patients with type 1 and type 2diabetes, respectively.
The drug device, designed to improve glycemic control,comprises the Afrezza inhalation powder and an inhaler toadminister it.
** ARATANA THERAPEUTICS INC, $24.99, up 6 pct (9:36a.m. ET)
The pet medication products maker said it would buyprivately-held Vet Therapeutics Inc in cash and stock to expandin products to treat lymphoma in dogs. The company will pay $30million in cash and issue about 625,000 shares to buy VetTherapeutics.
** ARIAD PHARMACEUTICALS INC, $4.07, down 4 pct(9:37 a.m. ET)
The U.S. Food and Drug Administration said it isinvestigating an increasing number of reports of serious andlife-threatening adverse events in patients taking the company'sleukemia drug, Iclusig. (Compiled by Sneha Banerjee in Bangalore; Editing by KirtiPandey)
